Search

Author/Creator Andreoni, M.

1. A close monitoring of virological and immunological hepatitis B markers can improve the diagnosis of HBV reactivation in HBsAg-negative/anti-HBc-positive patients with oncohematological diseases. (February 2019)

Authors:
Salpini, R.; Cerva, C.; Battisti, A.; Piermatteo, L.; Sacco, A.; Malagnino, V.; Arcese, W.; Cantonetti, M.; Ceccherini-Silberstein, F.; Perno, C.F.; Andreoni, M.; Sarmati, L.; Svicher, V.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 1
Page Start:
e67
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A hyper-glycosylation of HBV surface major hydrophilic region correlates with immunosuppression-driven HBV reactivation and hampers HBsAg recognition in vitro. (15th February 2015)

Authors:
Colagrossi, L.; Salpini, R.; Surdo, M.; Battisti, A.; Pollicita, M.; Bertoli, A.; Di Santo, F.; Becker, C.; Mastroianni, C.; Marignani, M.; Maylin, S.; Delaugerre, C.; Morisco, F.; Coppola, N.; Marrone, A.; Sarmati, L.; Andreoni, M.; Angelico, M.; Verheyen, J.; Perno, C.F.
Journal:
Digestive and liver disease
Issue:
Volume 47(2015)Supplement 1
Page Start:
e11
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. An elevated degree of genetic variability characterizes Hepatitis Delta Antigen (HDAg) and correlates with high levels of serum HDV-RNA: Implication for disease progression and design of new pharmacological targets. Issue 1 (16th February 2017)

Authors:
Colagrossi, L.; Salpini, R.; Scutari, R.; Battisti, A.; Piermatteo, L.; Bertoli, A.; Minichini, C.; Trimoulet, P.; Fleury, H.; Nebuloso, E.; De Cristofaro, M.; Cappiello, G.; Spanò, A.; Malagnino, V.; Mari, T.; Barlattani, A.; Iapadre, N.; Lichtner, M.; Mastroianni, C.M.; Lenci, I.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e40
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Analysis of resistance and phylogenetic clusters in HCV-2c infected patients within the Italian network Vironet C. (February 2020)

Authors:
Barbaliscia, S.; Di Maio, V.C.; Fabeni, L.; Teti, E.; Paolucci, S.; Minichini, C.; Aragri, M.; Rosa, K. Yu La; Carioti, L.; Pasquazzi, C.; Milana, M.; Foroghi, L.; Pollicino, T.; Licata, A.; Pieri, A.; Palitti, V. Pace; Bruzzone, B.; Micheli, V.; Bertoli, A.; Baiocchi, L.
Journal:
Digestive and liver disease
Issue:
Volume 52(2020)Supplement 1
Page Start:
e24
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study. (21st January 2016)

Authors:
Kovari, Helen; Sabin, Caroline A.; Ledergerber, Bruno; Ryom, Lene; Reiss, Peter; Law, Matthew; Pradier, Christian; Dabis, Francois; d'Arminio Monforte, Antonella; Smith, Colette; de Wit, Stephane; Kirk, Ole; Lundgren, Jens D.; Weber, Rainer; Powderly, B.; Shortman, N.; Moecklinghoff, C.; Reilly, ...
Journal:
Open forum infectious diseases
Issue:
Volume 3:Number 1(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance. (February 2019)

Authors:
Barbaliscia, S.; Di Maio, V.C.; Teti, E.; Aragri, M.; Paolucci, S.; Masetti, C.; D'Ambrosio, R.; Degasperi, E.; Polilli, E.; Palitti, V. Pace; Fiorentino, G.; Foroghi, L.; Cento, V.; Scutari, R.; Bruzzone, B.; Calvaruso, V.; Coppola, N.; Gaeta, G.B.; Morsica, G.; Ghisetti, V.
Journal:
Digestive and liver disease
Issue:
Volume 51(2019)Supplement 1
Page Start:
e65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Characterization of resistance profiles in HCV 2-3-4 DAA-naïve and DAA-experienced infected patients in Italy. Issue 1 (February 2018)

Authors:
Barbaliscia, S.; Di Maio, V.C.; Teti, E.; Lenci, I.; Aragri, M.; Polilli, E.; Fiorentino, G.; Pace Palitti, V.; Bruzzone, B.; Paolucci, S.; Coppola, N.; Ruggiero, T.; Pollicino, T.; Niero, F.; Micheli, V.; Nicolini, L.A.; Marenco, S.; Bertoli, A.; Maida, I.; Francioso, S.
Journal:
Digestive and liver disease
Issue:
Volume 50:Issue 1(2018)Supplement
Page Start:
46
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Clinical relevance of accurate HCV genotype and subtype assignment by NS3/NS5A/NS5B direct sequencing in the era of new direct acting antiviral agents. (10th February 2016)

Authors:
Aragri, M.; Di Maio, V.C.; Di Paolo, D.; Cento, V.; De Leonardis, F.; Gianserra, L.; Tontodonati, M.; Micheli, V.; Landonio, S.; Manunta, A.; Bertoli, A.; Ciotti, M.; Antonucci, F.P.; Campoli, R.; La Rosa, K. Yu; Deodati, F.; Lenci, I.; Francioso, S.; Nicolini, L.A.; Marenco, S.
Journal:
Digestive and liver disease
Issue:
Volume 48(2016)Supplement 1
Page Start:
e1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Clinical relevance of next generation sequencing on baseline detection of minority resistance associated variants in HCV-1 patients treated with protease inhibitors. (15th February 2015)

Authors:
Armenia, D.; Carioti, L.; Di Maio, V.C.; Bellocchi, M.C.; Di Paolo, D.; Guerrieri, F.; Calvo, L.; Cento, V.; Tontodonati, M.; Micheli, V.; De Leonardis, F.; Aragri, M.; Polilli, E.; Manunta, A.; Magni, C.; Antonucci, F.P.; De Luca, F.; Sarrecchia, C.; Bertoli, A.; Lenci, I.
Journal:
Digestive and liver disease
Issue:
Volume 47(2015)Supplement 1
Page Start:
e48
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗